IRIS Accounts Production v26.2.0.496 SC715676 director 1.12.24 30.11.25 30.11.25 false true false false true false iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh SC715676 2024-11-30 SC715676 2025-11-30 SC715676 2024-12-01 2025-11-30 SC715676 2023-11-30 SC715676 2023-12-01 2024-11-30 SC715676 2024-11-30 SC715676 ns15:Scotland 2024-12-01 2025-11-30 SC715676 ns14:PoundSterling 2024-12-01 2025-11-30 SC715676 ns10:Director1 2024-12-01 2025-11-30 SC715676 ns10:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 SC715676 ns10:SmallEntities 2024-12-01 2025-11-30 SC715676 ns10:AuditExempt-NoAccountantsReport 2024-12-01 2025-11-30 SC715676 ns10:SmallCompaniesRegimeForDirectorsReport 2024-12-01 2025-11-30 SC715676 ns10:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 SC715676 ns10:FullAccounts 2024-12-01 2025-11-30 SC715676 ns10:RegisteredOffice 2024-12-01 2025-11-30 SC715676 ns5:CurrentFinancialInstruments 2025-11-30 SC715676 ns5:CurrentFinancialInstruments 2024-11-30 SC715676 ns5:ShareCapital 2025-11-30 SC715676 ns5:ShareCapital 2024-11-30 SC715676 ns5:RetainedEarningsAccumulatedLosses 2025-11-30 SC715676 ns5:RetainedEarningsAccumulatedLosses 2024-11-30 SC715676 ns5:PlantMachinery 2024-12-01 2025-11-30 SC715676 ns5:PlantMachinery 2024-11-30 SC715676 ns5:PlantMachinery 2025-11-30 SC715676 ns5:PlantMachinery 2024-11-30 SC715676 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-11-30 SC715676 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-11-30

REGISTERED NUMBER: SC715676 (Scotland)

Unaudited Financial Statements for the Year Ended 30 November 2025

for

Rbpharma Ltd

| Rbpharma Ltd (Registered number: SC715676) |

Contents of the Financial Statements

for the Year Ended 30 November 2025

Page |

| Company Information | 1 |

| Balance Sheet | 2 |

| Notes to the Financial Statements | 3 |

| Rbpharma Ltd |

Company Information

for the Year Ended 30 November 2025

| DIRECTOR: | Mr R Bentley

| REGISTERED OFFICE: | 24 Alderley Way

| Cumbernauld

| Lanarkshire

| G68 0GU

| REGISTERED NUMBER: | SC715676 (Scotland)

| ACCOUNTANTS: | Greg Hannah Ltd

| Chartered Accountants

| 26 Victoria Street

| Rutherglen

| Glasgow

| G73 1DS

| Rbpharma Ltd (Registered number: SC715676) |

Balance Sheet

30 November 2025

| 2025 | 2024 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Tangible assets | 5 | 365 |  | 675 |  |

CURRENT ASSETS

Debtors | 6 | - |  | 1,204 |  |

Cash at bank | 17,445 |  | 22,218 |  |

17,445 |  | 23,422 |  |

CREDITORS

Amounts falling due within one year | 7 | 17,385 |  | 23,778 |  |

NET CURRENT ASSETS/(LIABILITIES) | 60 |  | (356 | ) |

TOTAL ASSETS LESS CURRENT LIABILITIES | 425 |  | 319 |  |

CAPITAL AND RESERVES

Called up share capital | 100 |  | 100 |  |

Retained earnings | 325 |  | 219 |  |

425 |  | 319 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 17 August 2026 and were signed by:

Mr R Bentley - Director

| Rbpharma Ltd (Registered number: SC715676) |

Notes to the Financial Statements

for the Year Ended 30 November 2025

1. | STATUTORY INFORMATION

| Rbpharma Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

| The presentation currency of the financial statements is the Pound Sterling (£).

2. | STATEMENT OF COMPLIANCE

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. There were no material departures from that standard.

3. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| The financial statements have been prepared under the historical cost convention.

| Turnover

| Turnover is derived from pharmaceutical services supplied by the company.

| Turnover is measured at the fair value of the service supplied, net of discounts and is recognised at the point that the company obtains right to the consideration.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Plant and machinery etc | - | 25% on cost

| Taxation

| Taxation for the year comprises current tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Pension costs and other post-retirement benefits

| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

4. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 2 (2024 - 1 ) .

| Rbpharma Ltd (Registered number: SC715676) |

Notes to the Financial Statements - continued

for the Year Ended 30 November 2025

5. | TANGIBLE FIXED ASSETS

| Plant and

| machinery

| etc

£ |

| COST

| At 1 December 2024

| and 30 November 2025 | 1,238 |  |

| DEPRECIATION

| At 1 December 2024 | 563 |  |

| Charge for year | 310 |  |

| At 30 November 2025 | 873 |  |

| NET BOOK VALUE

| At 30 November 2025 | 365 |  |

| At 30 November 2024 | 675 |  |

6. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Other debtors | - |  | 1,204 |  |

7. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Taxation and social security | 12,496 |  | 13,601 |  |

| Other creditors | 4,889 |  | 10,177 |  |

17,385 |  | 23,778 |  |

8. | RELATED PARTY DISCLOSURES

| At the 30th November 2025, the company owed Mr R Bentley (Director) £4,889 (2024 £10,177). Miss K Morris (Shareholder) owed the company £NIL (2024 £1,204).

| These above loans are interest free and have no fixed repayment terms.